mPEG@ELA-11通过AKT-ER压力介导的巨细胞调节来缓解动脉样硬化
Xiaoguang Li1,2, Ning Dou1, Linshan Zhong3
1Center of Vascular Diseases, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai 200434, China.
BME frontiers
|November 27, 2025
概括
甲聚乙烯甘醇@Elabela-11 (mPEG@ELA-11) 酸纳米药物向巨细胞功能障碍,以减少动脉样硬化. 这种响应pH的合物通过调节AKT-ER应激通路来缓解斑块形成.
科学领域:
- 心血管研究研究心血管研究
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- 动脉样硬化是导致死亡的主要原因,由巨细胞功能障碍和脂质积累驱动.
- 埃拉贝拉片段 (ELA-11) 显示出对心血管的益处,但其在动脉样硬化和输送方法中的作用尚未被探索.
- 向巨细胞功能障碍为动脉样硬化提供了一个治疗策略.
研究的目的:
- 研究ELA-11在调节巨细胞功能和减轻动脉样硬化的作用.
- 作为分子标,探索 AKT 介导的内质网膜 (ER) 应激通路.
- 开发和评估一种新的pH响应纳米载体,mPEG@ELA-11,用于增强向药物输送.
主要方法:
- 在人类动脉样硬化斑块和患者血清ELA水平中分析了Elabela mRNA (APELA) 表达.
- 对RAW264.7巨细胞进行了体外研究,以评估mPEG@ELA-11对泡细胞形成,极化和亡的影响.
- 在ApoE-/-小鼠体内评估的疗效,具有pH响应释放和斑块减少的特征.
主要成果:
- 在人类动脉样硬化斑块,特别是不稳定的病变中,APELA的表达下调.
- 在体外,mPEG@ELA-11通过抑制AKT-ER应激途径来抑制巨细胞泡细胞的形成,M1极化和亡.
- 在体内,由于pH触发释放,mPEG@ELA-11与自由ELA-11相比,显示出优异的斑块面积减少.
结论:
- 响应pH的mPEG@ELA-11结合物通过通过AKT-ER应激通路调节巨细胞功能,有效地减轻动脉样硬化.
- mPEG@ELA-11具有有利的向性和安全性,是动脉样硬化治疗的有前途的纳米药物.
- 这项研究强调了使用向纳米载体治疗心血管疾病的新治疗策略.
更多相关视频
相关概念视频
01:26Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
01:30Atherosclerosis I: Introduction
818
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
818
01:23Atherosclerosis IV: Nursing Management
347
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
347
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
440
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
440